Table 3.

Antifungal activity of selected derivatives against clinical strains in comparison with C. albicans ATCC 10231.

Compound	*MIC90 µg mL−1
	Candida albicans ATCC 10231	Candida albicans B3	Candida albicans B4	Candida albicans Gu4	Candida albicans Gu5	Candida albicans F2	Candida albicans F5
3	16	16	32	16	32	16	32
5	16	64	64	64	64	32	64
6	16	16	64	16	64	32	32
7	16	32	64	32	32	32	32
8	32	32	32	32	32	32	32
9	4	8	8	8	8	8	8
12	8	64	64	64	64	> 64	> 64
13	8	16	16	16	16	16	16
14	8	16	16	8	8	8	8
15	8	8	8	8	8	8	8
42	8	8	8	8	8	8	8
44	4	4	4	4	4	4	4
45	32	64	64	64	64	64	64
Fluconazole	8	1	16	4	> 64	8	> 64

* > Means no activity at the concentration mentioned. In this assay, the MIC₉₀ value of fluconazole was recorded as a positive control. The experiments were performed at least in three replicates.